BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288 | -43.2% | 449 | 0.0% | 0.00% | – |
| Q2 2023 | $2,267 | -97.2% | 449 | -98.5% | 0.00% | – |
| Q1 2022 | $81,000 | -50.6% | 29,064 | -5.7% | 0.00% | – |
| Q4 2021 | $164,000 | -38.3% | 30,813 | -1.8% | 0.00% | – |
| Q3 2021 | $266,000 | -28.1% | 31,393 | +3.5% | 0.00% | – |
| Q2 2021 | $370,000 | -16.7% | 30,318 | +65.6% | 0.00% | -100.0% |
| Q1 2021 | $444,000 | -28.6% | 18,306 | -5.7% | 0.00% | 0.0% |
| Q4 2020 | $622,000 | +21.0% | 19,411 | +14.1% | 0.00% | 0.0% |
| Q3 2020 | $514,000 | -19.4% | 17,019 | +12.4% | 0.00% | 0.0% |
| Q2 2020 | $638,000 | +112.0% | 15,140 | +25.5% | 0.00% | 0.0% |
| Q1 2020 | $301,000 | – | 12,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |